The global multiple myeloma therapeutics market size was estimated at USD 20.87 billion in 2023 and is projected to reach USD 30.30 billion by 2030, growing at a CAGR of 5.5% from 2024 to 2030. This growth is primarily driven by ongoing research and development efforts by key pharmaceutical companies, regulatory approvals from health authorities, and the launch of new therapies and...